The Haworth Institute and Self-Centered Aesthetics
Plastic surgeon Randal Haworth, MD, is taking the next step in his career with the launch of a stylish, comprehensive aesthetic care facility.

Randal Haworth, MD, made a name for himself in aesthetics in the early 2000s when he joined Fox television’s reality show, “The Swan.” On the program, he was part of a team of plastic surgeons, stylists and makeup artists who dramatically transformed participants’ appearances. Earlier this year, he transformed his own Beverly Hills, California-based practice when he moved to a new, custom-designed...

Articles

The Haworth Institute and Self-Centered Aesthetics

Randal Haworth, MD, made a name for himself in aesthetics in the early 2000s when he...

Attracting Male Aesthetic Patients

American men are more aware of their appearance than ever—and also more open to the...

MedEsthetics October 2017

The increasing availability and improved efficacy of non- and minimally invasive...

Business Consult October 2017

“The doctor is board certified.” This is the answer I hear most often when I ask a new...

Products

Neck Rejuvenation Treatment

Revision Skincare’s new Nectifirm ADVANCED targets the microbiome of the...

Nd:YAG picosecond laser

The PICOCARE from Wontech is a picosecond Nd:YAG laser featuring two...

Salicylic acid treatment

Formulated to clear blemishes and improve acne-prone skin, dm Skincare...

Three wavelength hair removal laser

Alma Lasers’ Soprano ICE platform now features three wavelengths—755nm,...

Blogs

Facebook Ad Leads
By Angela (Miller) Hamilton, Facebook Marketing Expert at ReachLocal With more than 1.71 billion active users on Facebook, social media advertising is an important way for medspas and medical practices to reach local consumers online. Most facilties have a company page and perhaps purchase a few...
Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Picoway Resolve Effective for Acne Scars

The 532nm/1,064nm Picoway Resolve picosecond holographic fractional handpiece (Syneron-Candela) improved acne scarring by an average of 28%, according to the results of a study published in Lasers in Surgery and Medicine (November 2017). Eric Bernstein, MD, et al, treated 31 subjects with either rolling or boxcar-type acne scars using either the 532nm wavelength or 1,064nm. Of the 27 subjects who completed the study, 19 were treated with 1,064nm and eight with 532nm. All underwent four monthly treatments.

Facial photography—including both cross polarized and parallel polarized photography—was performed prior to treatment and 12 weeks after the last treatment using Canfield Scientific’s Visia CR system. Results were graded by three physician evaluators and subject self-assessment. At each treatment session, two passes were administered to the affected areas in rows at right angles to one another—one vertical and one horizontal. The treating physician determined energy settings with erythema and mild petechiae as desired endpoints.

After averaging scores from the three blinded evaluators, 22 of 27 (81%) subjects showed some level of improvement; 13 of the 27 (48%) subjects had a mean improvement score of...

Facial Erosive Pustular Dermatosis A Risk of Ablative Skin Resurfacing

Physicians performing ablative laser skin resurfacing and medium-depth chemical peels should be aware of a potential, difficult-to-treat complication: facial erosive pustular dermatosis. Julie E. Mervak, MD, et al, examined the cases of three women who presented with persistent facial erosions after resurfacing procedures—either fully ablative CO2 laser or medium-depth Jessner/TCA chemical peel—for actinic damage, and were subsequently diagnosed with facial erosive pustular dermatosis. The case series was published in JAMA Dermatology (October 2017).

All three patients were women in their 50s or 60s and, in all three cases, treatment was challenging and improvement occurred slowly over months to years. Treatment included a combination of topical and systemic therapies, such as corticosteroids, dapsone, isotretinoin, and/or antibiotics. The researchers noted that watchful waiting (tincture of time) appeared to be central to the healing process.

The cases series was published to inform physicians that facial erosive pustular dermatosis should be considered in the differential diagnosis of nonhealing erosions following cosmetic skin resurfacing procedures, and treatment may require the use of...

Cutera Announces New Medical Advisory Board Members

Aesthetic device manufacturer Cutera has a new medical advisory board that began meeting in October 2017 under the leadership of Jeffrey Dover, MD, FRCPC, associate professor of clinical dermatology at Yale University School of Medicine, and associate professor of dermatology at Brown Medical School. The board includes:

Neil Sadick, MD, dermatologist, clinical professor of dermatology at Weill Cornell Medical College and founder of Sadick Dermatology

E. Victor Ross, MD, a dermatologist at Scipps Clinic, who specializes in laser surgery, cosmetic and general dermatology

Jeffrey Hsu, MD, dermatologist, associate professor at University of Illinois at Chicago, and co-director of dermatologic, cosmetic and laser surgery at the Dermatology Institute of DuPage Medical Group

Omar Ibrahimi, MD, PhD, dermatologist, and founder and medical director of the Connecticut Skin Institute

Rick Green, MD, FACS, plastic surgeon and medical director at Salmon Creek Plastic Surgery

The board will offer insights and direction to help Cutera with its future product pipeline. “We are honored to welcome this prestigious group...

Biologic Therapy Dupixent (Dupilumab) Approved For Atopic Dermatitis

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic dermatitis (AD).


Dupixent is a human monoclonal antibody that is designed to specifically inhibit overactive signaling of two key proteins, IL-4 and IL-13, which are believed to be major drivers of the persistent underlying inflammation in AD. It comes in a pre-filled syringe and can be self-administered as a subcutaneous injection every other week after an initial loading dose and can be used... more »

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.


According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »